A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)
Status:
Completed
Trial end date:
2017-05-13
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the effectiveness and safety of the study drug
known as duloxetine in participants with diabetic peripheral neuropathic pain.